Clinical Trials in San Antonio

Showing 4041-4060 of 14,064 trials

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

NCT01906385

This is a multi-center, sequential cohort, open-label, volume and dose escalation study of the safety, tolerability, and distribution of 186RNL given by convection enhanced delivery to patients with recurrent or progressive malignant glioma after standard surgical, radiation, and/or chemotherapy treatment. The study uses a modified Fibonacci dose escalation, followed by an expansion at the maximum tolerated dose (MTD) to determine efficacy. The starting absorbed dose is 1mCi in a volume of 0.660mL.

Glioma

Plus Therapeutics55 participantsStarted Jun 2015

Manhasset, New York, United States • Dallas, Texas, United States • San Antonio, Texas, United States

RECRUITINGPhase 2< 1 mile

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

NCT04291105

This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will enroll patients with three distinct separate tumor cohorts. The cancers types are colorectal, head and neck carcinoma, and melanoma that are progressing on CPI treatment.

MelanomaHead and Neck Squamous Cell CarcinomaColo-rectal Cancer

Vyriad, Inc.87 participantsStarted Apr 2020

Phoenix, Arizona, United States • Durate, California, United States • Los Angeles, California, United States +24 more locations

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Find Trials by Condition in San Antonio

Oral Administration of STC-15 in Subjects With Advanced Malignancies

Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC

Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female Subjects

BATwire Implant Kit

A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States

Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participants

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799)

Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey

Efficacy of Emotionally Focused Therapy Among Spanish Speaking Couples

In-Utero Endoscopic Correction of Spina Bifida

Kids FACE FEARS Comparative Effectiveness Research

Urine CXCL10 Monitoring Trial in Kidney Transplant